The best studied animal models for ARS are mice, canines, and non-human primates (NHP). An alternative large animal model would be advantageous for countermeasure development, to provide flexibility in matching compounds to a suitable species in terms of pharmacological parameters. Swine are increasingly used in drug development because of the similarity of their anatomy and physiology to those of humans. We demonstrate here the Gottingen minipig is a viable model in terms of practicality of whole-body gamma-irradiation, reliability of serial blood sampling from unanesthetized animals, and responses to ionizing radiation similar to what is observed in canines, NHP, and humans.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2010
Total Cost
$695,439
Indirect Cost
Name
Office of the Director, National Institutes of Health
Department
Type
DUNS #
City
State
Country
Zip Code